LEO is claiming global commercial rights to Spevigo for GPP, but will also collaborate with Boehringer on potential follow-up IL-36 mediated skin diseases, such as palmoplantar pustulosis and ...

Check out our VNDA stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.

Generic and biosimilar specialist Sandoz is strengthening its footprint in Slovenia, pledging $440 million to set up a new biosimilar facility for sterile product manufacturing some 24 miles from ...